News
-
CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody) ASCO 2026 Key Highlights
-
Caledonia Mining Corporation Plc: Director/PDMR Shareholding Notification
-
Caledonia Mining Corporation Plc: Utilisation of the Block Admission in Respect of ATM Sales Agreement
-
Exercise of Options
-
Redwood AI Enters LOI to Explore Pathogen Tracking Through AI Genomics at the Border of Rwanda and the Democratic Republic of Congo with Aim of Potentially Tracing Ebola Virus Disease
-
OHB and Helsing joint venture bridges the gap to start-ups – Alliance for Europe’s space sector takes shape
-
EQS-Adhoc: KHD Humboldt Wedag International AG: KHD wins major contract in the USA
-
Kora Joins International Air Transport Association's (IATA) Payment Network to Power Airline Payments Across Africa
-
Simcere Pharmaceutical Enters into a Research Collaboration Agreement with Stanford Medicine to Develop Innovative Therapies for Patients with Idiopathic Pulmonary Fibrosis
-
CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody) ASCO 2026 Key Highlights
-
CHANGE IN THE SHARE CAPITAL
-
Pricing of Green Senior Secured Notes due 2031 by Neoen FINCO PLC
-
Mersen joins the SBF 120 index
-
BAIKOWSKI: Annual General Meeting of June 11, 2026 - Dividend of €0.30 per share, to be paid out on June 30, 2026
-
Air Liquide and ArianeGroup renew strategic industrial partnership with two major Ariane 6 contracts